vs
Side-by-side financial comparison of ASIA PACIFIC WIRE & CABLE CORP LTD (APWC) and Axsome Therapeutics, Inc. (AXSM). Click either name above to swap in a different company.
ASIA PACIFIC WIRE & CABLE CORP LTD is the larger business by last-quarter revenue ($225.3M vs $196.0M, roughly 1.1× Axsome Therapeutics, Inc.).
Disney Networks Group Asia Pacific was a Hong Kong–based commercial broadcasting company operating multiple specialty television channels. The company was founded in 1991 by Hong Kong - Canadian businessman Richard Li.
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
APWC vs AXSM — Head-to-Head
Income Statement — Q2 FY2022 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $225.3M | $196.0M |
| Net Profit | — | $-28.6M |
| Gross Margin | 7.9% | — |
| Operating Margin | 2.2% | -13.8% |
| Net Margin | — | -14.6% |
| Revenue YoY | — | 65.0% |
| Net Profit YoY | — | 61.9% |
| EPS (diluted) | — | $-0.55 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $196.0M | ||
| Q3 25 | — | $171.0M | ||
| Q2 25 | — | $150.0M | ||
| Q1 25 | — | $121.5M | ||
| Q4 24 | — | $118.8M | ||
| Q3 24 | — | $104.8M | ||
| Q2 24 | — | $87.2M | ||
| Q1 24 | — | $75.0M |
| Q4 25 | — | $-28.6M | ||
| Q3 25 | — | $-47.2M | ||
| Q2 25 | — | $-48.0M | ||
| Q1 25 | — | $-59.4M | ||
| Q4 24 | — | $-74.9M | ||
| Q3 24 | — | $-64.6M | ||
| Q2 24 | — | $-79.3M | ||
| Q1 24 | — | $-68.4M |
| Q4 25 | — | -13.8% | ||
| Q3 25 | — | -27.0% | ||
| Q2 25 | — | -24.5% | ||
| Q1 25 | — | -46.9% | ||
| Q4 24 | — | -61.1% | ||
| Q3 24 | — | -59.8% | ||
| Q2 24 | — | -89.5% | ||
| Q1 24 | — | -89.7% |
| Q4 25 | — | -14.6% | ||
| Q3 25 | — | -27.6% | ||
| Q2 25 | — | -32.0% | ||
| Q1 25 | — | -48.9% | ||
| Q4 24 | — | -63.1% | ||
| Q3 24 | — | -61.7% | ||
| Q2 24 | — | -91.0% | ||
| Q1 24 | — | -91.1% |
| Q4 25 | — | $-0.55 | ||
| Q3 25 | — | $-0.94 | ||
| Q2 25 | — | $-0.97 | ||
| Q1 25 | — | $-1.22 | ||
| Q4 24 | — | $-1.54 | ||
| Q3 24 | — | $-1.34 | ||
| Q2 24 | — | $-1.67 | ||
| Q1 24 | — | $-1.44 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $322.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $88.3M |
| Total Assets | — | $689.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $322.9M | ||
| Q3 25 | — | $325.3M | ||
| Q2 25 | — | $303.0M | ||
| Q1 25 | — | $300.9M | ||
| Q4 24 | — | $315.4M | ||
| Q3 24 | — | $327.3M | ||
| Q2 24 | — | $315.7M | ||
| Q1 24 | — | $331.4M |
| Q4 25 | — | $88.3M | ||
| Q3 25 | — | $73.7M | ||
| Q2 25 | — | $73.1M | ||
| Q1 25 | — | $53.2M | ||
| Q4 24 | — | $57.0M | ||
| Q3 24 | — | $92.9M | ||
| Q2 24 | — | $102.9M | ||
| Q1 24 | — | $144.0M |
| Q4 25 | — | $689.8M | ||
| Q3 25 | — | $669.3M | ||
| Q2 25 | — | $639.8M | ||
| Q1 25 | — | $596.7M | ||
| Q4 24 | — | $568.5M | ||
| Q3 24 | — | $561.5M | ||
| Q2 24 | — | $548.2M | ||
| Q1 24 | — | $545.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-18.7M |
| Free Cash FlowOCF − Capex | — | $-18.7M |
| FCF MarginFCF / Revenue | — | -9.6% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-93.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-18.7M | ||
| Q3 25 | — | $1.0M | ||
| Q2 25 | — | $-32.4M | ||
| Q1 25 | — | $-43.4M | ||
| Q4 24 | — | $-26.2M | ||
| Q3 24 | — | $-18.6M | ||
| Q2 24 | — | $-30.1M | ||
| Q1 24 | — | $-53.5M |
| Q4 25 | — | $-18.7M | ||
| Q3 25 | — | $988.0K | ||
| Q2 25 | — | $-32.4M | ||
| Q1 25 | — | $-43.7M | ||
| Q4 24 | — | $-26.2M | ||
| Q3 24 | — | $-18.7M | ||
| Q2 24 | — | $-30.2M | ||
| Q1 24 | — | $-53.6M |
| Q4 25 | — | -9.6% | ||
| Q3 25 | — | 0.6% | ||
| Q2 25 | — | -21.6% | ||
| Q1 25 | — | -36.0% | ||
| Q4 24 | — | -22.1% | ||
| Q3 24 | — | -17.9% | ||
| Q2 24 | — | -34.6% | ||
| Q1 24 | — | -71.4% |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 0.1% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
